With reports of adverse reactions after the usage of commonly-used antibiotics, the Central Drugs Standard Control Organisation (CDSCO) has now asked manufacturers to ensure that this information be made available to the general public.
In a letter to drug manufacturers, CDSCO asked them to mention in leaflets inserted into drug packets or on promotional literature, information about the adverse reactions of these medicines. All of the seven formulations — antibiotics Cefotaxime, Ofloxacin and Cefixime; Tranexamic Acid, used to control bleeding; antipsychotic drug Quetiapine; anti-rheumatoid drug Sulfasalazine and the anti-epileptic medicine Sodium Valproate — have been instructed to warn patients of the new side effects. The letter was sent out by CDSCO on April 9.
Eswara Reddy, the Drug Controller General of India and head of the CDSCO said, ‘We were alerted to this adverse reaction last year and, after talks with the Ministry and the PvPI, the decision was taken to write to all State authorities to ask manufactures to include this information on the packaging itself. The idea is to ensure that doctors and users are aware of the adverse reactions.’